Clinical Trials Sponsored by Bioven Europe

Total 4163 results

Svelte Medical Systems Europe

Terminated

Acrobat Coronary Stent System Effectiveness European Study (ACES)

Coronary Artery Disease

Spain, France, Belgium
Aeon Astron Europe B.V.

Unknown

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany

Open-angle Glaucoma

Germany
Otsuka Pharmaceutical Europe Ltd

Completed

Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain (PROSIGO)

Schizophrenia

Spain
Otsuka Pharmaceutical Europe Ltd

Completed

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain (ALGA)

Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

Spain
Otsuka Pharmaceutical Europe Ltd

Completed

An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy (ASSERT)

Cancer | Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

Italy
Otsuka Pharmaceutical Europe Ltd

Completed

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH (SAMPLE)

Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

Germany, Spain
Otsuka Pharmaceutical Europe Ltd

Completed

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy (DOMINO)

Schizophrenia

Italy
La-ser Europe Limited

Completed

Effectiveness Study of Atrial Fibrillation (EFFECT-AF)

Atrial Fibrillation

Germany
Medical Enterprises Europe B.V.

Withdrawn

SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I (SHTC-EUROPE-1)

Neoplasms | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms
InCROM Europe Clinical Research

Completed

Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects

Anaemia | Chronic Kidney Failure
Olympus Surgical Technologies Europe

Terminated

Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP

Benign Prostatic Hypertrophy

China
Olympus Surgical Technologies Europe

Withdrawn

Safety and Efficacy of Using PK Morcellator With Pneumoliner Containment Hysterectomy

Gynecologic Surgery
Terumo Europe N.V.
Cromsource

Completed

DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention

Coronary Disease

Italy, Belgium, United Kingdom, Hungary, Japan, Czechia, Germany, Netherlands, North Macedonia, Switzerland
Medical Enterprises Europe B.V.

Terminated

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Neoplasms | Urologic Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Urinary Bladder Cancer | Malignant Tumor of Urinary Bladder

Austria, Israel, Italy, Netherlands
Chugai Pharma Europe Ltd.

Completed

Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors

Solid Tumors

United Kingdom
Alcyone Therapeutics, Inc
Biogen

Recruiting

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy (PIERRE)

Scoliosis | Spinal Muscular Atrophy | Spine Deformity

United States
Ionis Pharmaceuticals, Inc.
Biogen

Active, not recruiting

HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome

Angelman Syndrome

United States, Israel, Italy, France, Australia, United Kingdom
University Hospital, Bordeaux
Biogen

Completed

Safety of Exposure to Natalizumab During Pregnancy (BABYZUMAB-2)

Multiple Sclerosis

France, Martinique
University of Nebraska
Biogen

Completed

The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients (remapping)

Multiple Sclerosis

United States
Biogen
Ionis Pharmaceuticals, Inc.

Completed

An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C))

Amyotrophic Lateral Sclerosis

United States, Canada, Belgium, France, Australia, Japan, Denmark, Korea, Republic of, United Kingdom, Germany, Italy, Poland
Virginia Simnad
Biogen

Unknown

Impact of Tecfidera on Gut Microbiota

Multiple Sclerosis

United States
Astellas Pharma Inc
Biogen

Completed

A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis

Psoriatic Arthritis

Poland, Canada, United States, Russian Federation, Germany
Johns Hopkins University
Biogen

Withdrawn

Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
Astellas Pharma Inc
Biogen

Completed

Community Based Trial for AMEVIVE®

Moderate to Severe Chronic Plaque Psoriasis

United States
Astellas Pharma Inc
Biogen

Completed

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

Chronic Plaque Psoriasis

United States, Austria, Germany, Belgium, Canada
CryoLife Europa

Completed

PerClot Compared to Usual Care in Gynaecology Procedures

Cancer | Endometriosis | Uterine Fibroids | Menorrhagia | Ovarian Cyst

Spain
Biogen
Denali Therapeutics Inc.

Recruiting

A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80 (LUMA)

Parkinson Disease

United States, Netherlands, Italy, Spain, Israel, Canada, China, Germany, France, Austria, United Kingdom, Poland, Japan
Biogen
Denali Therapeutics Inc.

Terminated

A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (LIGHTHOUSE)

Parkinson Disease

United States, Italy, Spain, Germany, France, United Kingdom
University Hospital, Tours
Biogen

Completed

Frequency of SOD1 and C9orf72 Gene Mutations in French ALS (GENIALS)

Amyotrophic Lateral Sclerosis

France
Biogen
Eisai Co., Ltd.

Completed

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

Healthy Volunteers

United States
Biogen
Denali Therapeutics Inc.

Completed

A Study of Mass Balance, Pharmacokinetics, Metabolite Profile, and Metabolite Identification of BIIB122/DNL151 in Healthy Male Subjects

Healthy Volunteers

United States
University of Florida
Biogen

Completed

A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy (TWEAK)

Sarcopenia

United States
University Hospital Muenster
Biogen

Completed

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)

Multiple Sclerosis, Relapsing-Remitting

Germany
Hoffmann-La Roche
Biogen

Completed

A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

Rheumatoid Arthritis

Belgium, France, Germany, Norway, United Kingdom, United States, Ireland, Canada, Israel, Netherlands, Italy
Saint Francis Care
Biogen

Completed

Assessing Tolerability of Avonex Intramuscular Injections

Multiple Sclerosis

United States
Astellas Pharma Inc
Biogen

Completed

Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

Psoriasis

Belgium, Spain, Germany, United States, France, Canada, Denmark, Netherlands, United Kingdom
Astellas Pharma Inc
Biogen

Completed

A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis

Chronic Plaque Psoriasis

United States, Canada
Trio Medicines Ltd.
Biogen

Completed

Avonex®: Safety, Blood Levels and Effects (C-851)

Multiple Sclerosis (MS)

United Kingdom
University of Pittsburgh
Biogen

Completed

Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

Non-Hodgkin Lymphoma

United States
Biomet Orthopedics, LLC

Withdrawn

A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Humeral Fractures
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the Copeland™ Humeral Resurfacing Head

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Humeral Fractures
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the M2a-Magnum™ Hip System

Arthritis | Rheumatoid Arthritis | Osteoarthritis, Hip | Joint Disease | Bone Disease
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the M2a- 38™ Hip System

Osteoarthritis | Avascular Necrosis | Non-inflammatory Degenerative Joint Disease
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the Oxford® Partial Knee System

Osteoarthritis
Zimmer Biomet
Biomet U.K. Ltd.

Terminated

Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings

Femoral Neck Fractures

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Terminated

ReCap Total Hip Resurfacing Prospective Data Collection

Arthritis

United Kingdom
Zimmer Biomet
Biomet France SARL

Completed

Data Collection on ReCap/Magnum in Total Hip Replacement and Resurfacing

Total Hip Resurfacing

France
Biomet Orthopedics, LLC

Terminated

Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement

Osteoarthritis, Hip | Traumatic Arthritis of Hip

United States
CryoLife Europa

Completed

Characterization of Aortic Tissue at Reoperation

Aortic Aneurysm | Aortic Dissection

Italy
CryoLife Europa

Completed

Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery

Thoracic Aortic Aneurysm | Aortic Valve Replacement | Type A Aortic Dissection | Cardiovascular Procedures

Germany, Italy

Clinical Trials Sponsored by Bioven Europe

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations